Overview

Olanzapine Versus Comparator in the Treatment of Bipolar Disorder

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is compare the efficacy of olanzapine and Lithium Carbonate in the treatment of bipolar disorder, manic or mixed episodes, in Chinese patients.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Lithium Carbonate
Olanzapine